News | July 22, 2014

CT Datasets Now Enable Patient Specific Endovascular Procedure Simulation

July 22, 2014 — Simbionix USA announced the signing of a collaboration agreement with Pie Medical Imaging BV. The company manufactures and distributes the 3mensio software, a clinical application that enables the visualization and analysis of patient computed tomography (CT) scans in both 2-D and 3-D modes. The collaboration will enable the exporting of the 3mensio Vascular model into the Simbionix simulation environment to form a comprehensive planning solution that combines 3DR, data analysis and simulation on the same platform.

The solution will allow physicians and clinical specialists to rehearse a procedure in a complete virtual environment without the need for physical tools. This will take users of the 3mensio software to the next level of preparedness for endovascular procedures, as it will allow added simulation insights. Cases created by the software may also be imported to the Angio Mentor simulator for full procedure practice using fluoroscopy, guidewires, catheters and other equipment that is used in the cath lab.

Simbionix’s PROcedure Rehearsal Studio (PRS) steps up simulation by enabling physicians to rehearse a complete endovascular procedure on a virtual 3-D anatomical model based on a specific patient's CT data. The virtual model can be used for simulating, analyzing and evaluating pre-operative surgical treatment options prior to performing an actual case, which may increase a physician's confidence in the upcoming procedure. Simbionix recently received CE mark for its patient specific simulation.

In addition, Simbionix PRS has recently been granted a patent in China. The company now has patents for this technology in three key countries: the U.S., U.K. and China. These patents represent recognition for Simbionix's comprehensive line of products.

Gary Zamler, Simbionix CEO, said, "Growing interest from the image analysis market, which 3mensio is part of, demonstrates the need for more comprehensive planning solutions. The ability to evaluate surgical treatment options using simulation anytime, anywhere, is a major factor in achieving the goal to increase patient safety and improve procedure outcomes. The collaboration agreement, CE mark and additional patent are all examples of the company's key position as a market leader and innovator in the field of medical simulation."

For more information: www.simbionix.com

Related Content

FFR-CT

An example of a FFR-CT study showing a 3-D reconstruction of the coronary tree and a color overlay of virtual FFR readings, including a severe blockage in need of revascularization in the left anterior decending artery. 

News | CT Angiography (CTA)| August 21, 2015
August 21, 2015 — Loyola University Medical Center is the first and only hospital in Illinois to offer a new, noninva
IMRIS, going concern sale, Deerfield Management Company L.P., imaging and service, robotics intellectual property
News | Cath Lab| August 14, 2015
IMRIS Inc. announced in late July that investment funds managed by Deerfield Management Company L.P. (“Deerfield”) were...
Sponsored Content | Videos | Computed Tomography (CT)| August 07, 2015
DAIC Editor Dave Fornell shares some of the most innovative new technologies shown on the expo floor and discusses in
Sponsored Content | Videos | Computed Tomography (CT)| August 05, 2015
Interview with James Min, M.D., Professor of Radiology and Medicine and Director of Dalio Institute of Cardiovascular
Sponsored Content | Videos | 3-D Printing| August 05, 2015
Interview with Dee Dee Wang, M.D., FACC, FASE, advanced structural heart imaging staff cardiologist, Henry Ford Hospi
Sponsored Content | Videos | Computed Tomography (CT)| August 05, 2015
Interview with Daniel Berman, M.D., FACC, chief of Cardiac Imaging and Nuclear Cardiology, professor of imaging, Ceda
Sponsored Content | Videos | Computed Tomography (CT)| August 05, 2015
Interview with Harold Litt, M.D., Ph.D., chief of cardiovascular imaging section and associate professor of radiology
Sponsored Content | Videos | Computed Tomography (CT)| August 05, 2015
Interview with Ricardo Cury, M.D., FAHA, FSCCT, FACC, president of the Society of Cardiovascular Computed Tomography
Guerbet, acquisition, Mallinckrodt, CMDS business, contrast media, CT, MRI
News | Contrast Media| July 29, 2015
Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast...
Vital Images, Toshiba, CT Myocardial Perfusion, cardiac CT, CORE 320 study
Technology | July 15, 2015
Vital Images Inc. will debut its U.S. Food and Drug Administration (FDA) 510(k)-cleared CT Myocardial Perfusion...
Overlay Init